Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market opportunities. See why TEM stock is a Buy.

Erik Phelps, the Executive Vice President and Chief Administrative and Legal Officer of Tempus AI , Inc. (NASDAQ:TEM), ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Andrew Polovin, the Executive Vice President and General Counsel of Tempus AI , Inc. (NASDAQ:TEM), a company currently valued at $10.2 billion, recently executed a stock sale as part of a pre-arranged ...

Collaboration focuses on launching an AI-powered biomarker prediction panel targeting actionable biomarkers to revolutionize lung cancer diagnostics and enable commercialization of a diagnostic panel.

Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.

"Tempus has an unwavering commitment to providing ... from previously diagnosed cancer patients with solid malignant neoplasms. The test is intended as a companion diagnostic (CDx) to identify ...

Tempus then sends the provider a notification for each patient that may be a match for that trial. Patient Timeline: Every patient’s journey is unique. Throughout their care, a cancer patient ...

The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.

Tempus AI was one of them ... language models (LLM), a platform that it says is 50 times larger than The Cancer Genome Atlas (TCGA). This is just a momentum move in TEM stock unrelated to its ...

Tempus AI shares were up 14% ... instability status and companion diagnostic claims for colorectal cancer patients, said the Chicago-based company.

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence ... aimed at enhancing personalized treatment for hematological cancer patients. According to InvestingPro data, the ...